Zobrazeno 1 - 10
of 733
pro vyhledávání: '"Dean J. Kereiakes"'
Autor:
Sem A. O. F. Rikken, Arnoud W. J. van 't Hof, Jurriën M. ten Berg, Dean J. Kereiakes, Barry S. Coller
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 24 (2023)
Thrombocytopenia is a rare but serious complication of the intravenous glycoprotein IIb/IIIa (GPIIb/IIIa; integrin αIIbβ3) receptor inhibitors (GPIs), abciximab, eptifibatide, and tirofiban. The thrombocytopenia ranges from mild (50 000–100 000 p
Externí odkaz:
https://doaj.org/article/789d3593397e4ef4aaf7cdb7865ef657
Autor:
Yasar Sattar, Talal Almas, Junaid Arshad, Mohamed Zghouzi, Waqas Ullah, Tanveer Mir, Mohamed O. Mohamed, Islam Y. Elgendy, Wael Aljaroudi, Anand Prasad, Richard Shlofmitz, Mamas A. Mamas, Dean J. Kereiakes, M. Chadi Alraies
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 39, Iss , Pp 100975- (2022)
Background: Intravascular lithotripsy (IVL) can be used to assist stent deployment in severe coronary artery calcifications (CAC). Methods: Studies employing IVL for CAC lesions were included. The primary outcomes included clinical and angiographic s
Externí odkaz:
https://doaj.org/article/a6f1e278ac23483ea18076623982784f
Autor:
Alexander Thomas, MD, Dean J. Kereiakes, MD, Andreas Baumbach, MD, Stephan Windecker, MD, Cody Pietras, BA, Ovidiu Dressler, MD, M. Ozgu Issever, MS, Michael Curtis, MD, Barry Bertolet, MD, James P. Zidar, MD, Pieter C. Smits, MD, Victor Alfonso Jiménez Díaz, MD, Brent McLaurin, MD, Ángel Cequier, MD, Akihiko Takahashi, MD, PhD, Louis A. Cannon, MD, Giovanni Amoroso, MD, PhD, Tsunekazu Kakuta, MD, PhD, Shigeru Saito, MD, Martin B. Leon, MD, Alexandra J. Lansky, MD
Publikováno v:
Journal of the Society for Cardiovascular Angiography & Interventions, Vol 1, Iss 2, Pp 100033- (2022)
Background: Patients with diabetes mellitus (DM) have worse outcomes following percutaneous coronary intervention than nondiabetic patients. The novel Supreme DES is a biodegradable polymer sirolimus-eluting stent designed to synchronize early drug d
Externí odkaz:
https://doaj.org/article/54389ae712be4d02acb90049ca8e7178
Autor:
Dean J. Kereiakes, MD, Jonathan M. Hill, MD, Richard A. Shlofmitz, MD, Andrew J. Klein, MD, Robert F. Riley, MD, Matthew J. Price, MD, Howard C. Herrmann, MD, William Bachinsky, MD, Ron Waksman, MD, Gregg W. Stone, MD
Publikováno v:
Journal of the Society for Cardiovascular Angiography & Interventions, Vol 1, Iss 1, Pp 100001- (2022)
Background: Coronary calcification impairs stent delivery and optimal expansion, a significant predictor of subsequent stent thrombosis and restenosis. Current calcium ablative technologies may be limited by guidewire bias and periprocedural complica
Externí odkaz:
https://doaj.org/article/04b1821562164a07aab3e49d78e98a48
Outcomes of the Novel Supreme Drug-Eluting Stent in Complex Coronary Lesions: A PIONEER III Substudy
Autor:
Kush P. Patel, MBBS, Alexandra J. Lansky, MD, Dean J. Kereiakes, MD, Stephan Windecker, MD, Ecaterina Cristea, MD, Cody Pietras, BA, Ovidiu Dressler, MD, M. Ozgu Issever, MS, Michael Curtis, MD, Barry Bertolet, MD, James P. Zidar, MD, Pieter C. Smits, MD, Victor Alfonso Jiménez Díaz, MD, Brent McLaurin, MD, David A. Brogno, MD, Luc Janssens, MD, Mathias C. Vrolix, MD, Iván Gómez-Blázquez, MD, Zakir H. Sahul, MD, Ameer Kabour, MD, Luisa Salido, MD, Michael Cleman, MD, Shigeru Saito, MD, Martin B. Leon, MD, Andreas Baumbach, MD
Publikováno v:
Journal of the Society for Cardiovascular Angiography & Interventions, Vol 1, Iss 1, Pp 100004- (2022)
Background: The Supreme healing-targeted drug-eluting stent (DES) is designed to promote endothelial healing to reduce stent-related adverse events. This may be particularly relevant among complex lesions that have a higher rate of adverse events. We
Externí odkaz:
https://doaj.org/article/286ee59f3e6b42229dc94b210da97d9d
Autor:
Yasin Hussain, MD, Kathleen E. Kearney, MD, J. Dawn Abbott, MD, Dean J. Kereiakes, MD, Carlo Di Mario, MD, PhD, Shigeru Saito, MD, Ecaterina Cristea, MD, Robert F. Riley, MD, Jean Fajadet, MD, Richard A. Shlofmitz, MD, Ziad A. Ali, MD, DPhil, Andrew J. Klein, MD, Matthew J. Price, MD, Jonathan M. Hill, MD, Gregg W. Stone, MD, Alexandra J. Lansky, MD
Publikováno v:
Journal of the Society for Cardiovascular Angiography & Interventions, Vol 1, Iss 1, Pp 100011- (2022)
Background: Coronary artery calcification increases the procedural complexity of percutaneous coronary intervention and is associated with worse outcomes, especially in women. Intravascular lithotripsy (IVL) has been demonstrated to be safe and effec
Externí odkaz:
https://doaj.org/article/189e06da23e1445485253fd538aa51c8
Autor:
Ohad S. Bentur, Jihong Li, Caroline S. Jiang, Linda H. Martin, Dean J. Kereiakes, Barry S. Coller
Publikováno v:
TH Open, Vol 05, Iss 03, Pp e449-e460 (2021)
Introduction Prehospital therapy of ST-elevation myocardial infarction (STEMI) with αIIbβ3 antagonists improves clinical outcomes, but they are difficult to use in prehospital settings. RUC-4 is a novel αIIbβ3 antagonist being developed for preho
Externí odkaz:
https://doaj.org/article/44739d156a174cadbbd7ae35ef38e4b8
Autor:
Robert F. Riley, MD, MS, Dean J. Kereiakes, MD, Ehtisham Mahmud, MD, Timothy D. Smith, Cindy Grines, MD, Timothy D. Henry, MD
Publikováno v:
JACC: Case Reports, Vol 2, Iss 10, Pp 1651-1653 (2020)
Externí odkaz:
https://doaj.org/article/e219ec1801f843dcb5dddf78443e3a0c
Autor:
Dean J. Kereiakes, Tim D. Henry, Anthony N. DeMaria, Ohad Bentur, Marilyn Carlson, Corinne Seng Yue, Linda H. Martin, Jeff Midkiff, Michele Mueller, Terah Meek, Deborah Garza, C. Michael Gibson, Barry S. Coller
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 17 (2020)
Background Despite reductions in door‐to‐balloon times for primary coronary intervention, mortality from ST‐segment–elevation myocardial infarction has plateaued. Early pre–primary coronary intervention treatment of ST‐segment–elevation
Externí odkaz:
https://doaj.org/article/1929a15707574416aad6902e79d89e29
Autor:
Kashish Goel, Jared M. O’Leary, Colin M. Barker, Melissa Levack, Vivek Rajagopal, Raj R. Makkar, Tanvir Bajwa, Neal Kleiman, Axel Linke, Dean J. Kereiakes, Ron Waksman, Dominic J. Allocco, David G. Rizik, Michael J. Reardon, Brian R. Lindman
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 17 (2020)
Background Gait speed is a reliable measure of physical function and frailty in patients with aortic stenosis undergoing transcatheter aortic valve replacement (TAVR). Slow gait speed pre‐TAVR predicts worse clinical outcomes post‐TAVR. The conse
Externí odkaz:
https://doaj.org/article/c4ccb6fd14bf45c693db9ead80e84049